EDGAR Filing Documents for 0001554795-14-000230

Form 8-K - Current report:

SEC Accession No. 0001554795-14-000230

Filing Date

2014-03-28

Accepted

2014-03-28 16:11:49

Documents

Period of Report

2014-03-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gnbt32614form8k.htm	8-K	31248
2	EXHIBIT 3.1	gnbt32614form8kex3_1.htm	EX-3.1	153189
3	EXHIBIT 4.1	gnbt32614form8kex4_1.htm	EX-4.1	195997
4	EXHIBIT 4.2	gnbt32614form8kex4_2.htm	EX-4.2	81126
5	EXHIBIT 4.3	gnbt32614form8kex4_3.htm	EX-4.3	118812
6	PRESS RELEASE	gnbt32614form8kpr.htm	EX-99.1	13186
	Complete submission text file	0001554795-14-000230.txt		594853

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)